Dardare, J.; Witz, A.; Merlin, J.-L.; Bochnakian, A.; Toussaint, P.; Gilson, P.; Harlé, A.
Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic Opportunities. Pharmaceuticals 2021, 14, 740.
https://doi.org/10.3390/ph14080740
AMA Style
Dardare J, Witz A, Merlin J-L, Bochnakian A, Toussaint P, Gilson P, Harlé A.
Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic Opportunities. Pharmaceuticals. 2021; 14(8):740.
https://doi.org/10.3390/ph14080740
Chicago/Turabian Style
Dardare, Julie, Andréa Witz, Jean-Louis Merlin, Agathe Bochnakian, Paul Toussaint, Pauline Gilson, and Alexandre Harlé.
2021. "Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic Opportunities" Pharmaceuticals 14, no. 8: 740.
https://doi.org/10.3390/ph14080740
APA Style
Dardare, J., Witz, A., Merlin, J. -L., Bochnakian, A., Toussaint, P., Gilson, P., & Harlé, A.
(2021). Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic Opportunities. Pharmaceuticals, 14(8), 740.
https://doi.org/10.3390/ph14080740
